Excisional biopsy of a pigmented lesion reveals melanoma with a thickness of 1.5 mm. No ulceration or mitoses are present per the pathology report. What should be the margins or re-excision be?
Select Your Answer:
A 2 cm margin excision is considered appropriate for melanomas greater than 1 mm in thickness. A margin of 1 cm is also acceptable for melanomas of less than 2 mm in Breslow depth. In the 1-2 mm thickness range a 2 cm margin showed a lower local recurrence rate than a 1 cm margin, but there was no difference in overall survival.
Five cm margins were used in the past, but recent study indicates wider resection does not decrease the risk of melanoma recurrence.
The Breslow depth is a key determinate of prognosis. The Breslow depth for melanomas along with mitosis and ulceration determines the T-score, which in turn is used to determine the TNM staging of the tumor. For tumors without ulceration or mitosis tumor less than 1 mm thick are T1, tumors 1-2 mm thick are T2, tumors 2-4 mm thick are T3, and tumors >4mm in thickness are T4.
Clark classification defines level I - Involves only epidermis (in situ melanoma) no invasion; level II - Invades papillary dermis but not papillary-reticular dermal interface; level III - Invades and expands papillary dermis up to the interface with, but not into, reticular dermis; level IV - Invades reticular dermis but not into subcutaneous tissue; and level V - Invades into subcutaneous tissue.
*eMedicine, Google Scholar, UpToDate, WheelessOnline, and DermNet are not affiliated with StatPearls. We do not control their content or advertising.
[Update on Evidence-Based Review for the Management of Cutaneous Melanoma]., Namikawa K,, Gan to kagaku ryoho. Cancer & chemotherapy, 2016 Apr [PubMed PMID: 27254880]
Cancer treatment and survivorship statistics, 2016., Miller KD,Siegel RL,Lin CC,Mariotto AB,Kramer JL,Rowland JH,Stein KD,Alteri R,Jemal A,, CA: a cancer journal for clinicians, 2016 Jun 2 [PubMed PMID: 27253694]
Prognostic significance of hematological profiles in melanoma patients., Gandini S,Ferrucci PF,Botteri E,Tosti G,Barberis M,Pala L,Battaglia A,Clerici A,Spadola G,Cocorocchio E,Martinoli C,, International journal of cancer, 2016 Jun 2 [PubMed PMID: 27252119]
Distinct Genetic Profiles of Extracranial and Intracranial Acral Melanoma Metastases., Sharma G,Lian CG,Lin WM,Amin-Mansour A,Jané-Valbuena J,Garraway L,Bao W,Yoon CH,Ibrahim N,, Journal of cutaneous pathology, 2016 Jun 2 [PubMed PMID: 27251777]
Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma., van Akkooi AC,Atkins MB,Agarwala SS,Lorigan P,, American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, 2016 [PubMed PMID: 27249760]